Indication

Septic Shock Hyperdynamic

1 clinical trial

1 product

1 drug

Clinical trial

" Ilomedin for Treatment of Septic Shock With Persistent Microperfusion Defects ", a Double-blind, Randomized Controlled Trial:The I-MICRO Trial

Status: Completed, Estimated PCD: 2024-01-18

Product

Drug